HYALGAN 20MG/2ML SODIUM HYALURONATE 1 PREFILLED SYRINGE
Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.
Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
This medicine contains a combination of plant extracts.
Medicine based on avocado and soya unsaponifiables indicated for the symptomatic treatment (pain and discomfort during movement) with a delayed effect of osteoarthritis of the knee (Requires a medical diagnosis).
PIASCLÉDINE 300 box of 30 capsules.
Also available in boxes of 60 capsules and 90 capsules
| p capsules | |
| Unsaponifiables of avocado oil | 100 mg |
| Unsaponifiables of soybean oil | 200 mg |
Active ingredients: Unsaponifiables of avocado oil, Unsaponifiables of soya oil
Excipients: Butylated hydroxytoluene, Erythrosine, Yellow iron oxide, Gelatin, Polysorbate 80, Colloidal anhydrous silica, Titanium dioxide
The effect of this drug during pregnancy or lactation is not known. The evaluation of the possible risk related to its use is individual: ask your pharmacist or your doctor for advice.
The capsules should be swallowed with a glass of water, in the middle of meals.
1 capsule per day.
In the treatment of osteoarthritis, the effect of this medication is slow to appear: relief generally appears only after 1 to 2 months of treatment.
The drug treatment does not dispense with measures to fight against possible overweight. It is also recommended to practice an adapted physical activity to strengthen the muscles and maintain the mobility of the joint.
Rare regurgitation with a lipidic smell, allergic reaction.
Diarrhea, stomach pain.
Exceptionally: liver damage.
If you have experienced an adverse reaction that may be due to this medicine, you can report it by downloading the form.
See the Piascledine® 300 leaflet in the "Attached documents" tab
Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.
1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid
This medicine is used as a ground modifier especially during infectious and viral conditions, flu-like conditions, inflammatory rheumatic conditions and during arthrosis.
COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.
COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.
COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM must be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist doctor, to relieve the pain associated with osteoarthritis of the hip.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
Medical device used as a temporary substitute for synovial fluid in cases of degenerative joint damage, such as osteoarthritis of the knee and hip, which is responsible for a functional change in synovial fluid, without any active synovitis.
Intra-articular injection
Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.
Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.
Ostenil Plus is a transparent solution of natural and highly purified hyaluronic acid, obtained by bacterial fermentation and free of animal proteins. Ostenil Plus also contains mannitol, a free radical scavenger, which helps stabilize the hyaluronic acid chains. Biocompatibility studies have shown that Ostenil Plus is well tolerated.
Indications: This product is indicated in adults (over 15 years of age) for the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and contusions. This drug is indicated in adults for the treatment of painful flare-ups of osteoarthritis of the knee, following initial medical advice.
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.